IL18 and COVID-19: Whether promoting interleukin-18 or its consequences, such as IFNγ, might be helpful to prevent or treat COVID-19 could be considered, given these treatments are available [45, 46], and a small case series suggested promising results of using IFNγ in critically ill COVID-19 patients [46].